Literatur
[1] COVID-19 epidemiological update, Informationen der Weltgesundheitsorganisation, Edition 168, 17. Juni 2024, www.who.int/publications/m/item/covid-19-epidemiological-update-edition-168
[2] 7-Tage-Inzidenz. Informationen des Bundesministeriums für Gesundheit, infektionsradar.gesund.bund.de/de/covid/inzidenz, Stand: 24. Juni 2024
[3] AMELAG-Wochenbericht (Abwassermonitoring für die epidemiologische Lagebewertung) vom 12.06.2024, Informationen des Robert Koch-Instituts, www.rki.de/DE/Content/Institut/OrgEinheiten/Abt3/FG32/Abwassersurveillance/Abwassersurveillance.html
[4] Kaku Y et al. Virological characteristics of the SARS-CoV-2 KP.2 variant. Lancet Infect Dis 2024;24(7):e416, doi: 10.1016/S1473-3099(24)00298-6
[5] Kaku Y et al. Virological characteristics of the SARS-CoV-2 KP.3, LB.1 and KP.2.3 variants. BioRxiv 2024, doi: 10.1101/2024.06.05.597664
[6] Rosen A. What to Know About COVID FLiRT Variants. Informationen der John Hopkins School of Public Health, publichealth.jhu.edu/2024/what-to-know-about-covid-flirt-variants, Stand 13. Mai 2024
[7] Statement on the antigen composition of COVID-19 vaccines, Informationen der WHO, www.who.int/news/item/26-04-2024-statement-on-the-antigen-composition-of-covid-19-vaccines, Stand 26. April 2024
[8] Updated COVID-19 Vaccines for Use in the United States Beginning in Fall 2024, Informationen der FDA, www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2024, Stand: 5. Juni 2024
[9] EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for 2024-2025, Informationen der EMA, www.ema.europa.eu/en/documents/other/ema-recommendation-update-antigenic-composition-authorised-covid-19-vaccines-2024-2025_en.pdf, Stand: April 2024
[10] Neue Erkenntnisse über den Einfluss des Zelleintrittswegs von SARS-CoV-2-Viren auf den Ausgang der Infektion. Pressemitteilung 08/2024 des Paul Ehrlich Instituts
[11] Monu M et al. SARS-CoV-2 infects cells lining the blood-retinal barrier and induces a hyperinflammatory immune response in the retina via systemic exposure. PLoS Pathog 2024;20(4):e1012156, doi: 10.1371/journal.ppat.1012156
[12] COVID-19 Virus Could Damage Vision. Informationen der University of Missouri, medicine.missouri.edu/news/covid-19-virus-could-damage-vision, Stand 14. Mai 2024
[13] Haddrell A et al. Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection risk. Nat Commun 2024;15(1):3487, doi: 10.1038/s41467-024-47777-5
[14] Xie Y et al. Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024. JAMA 2024;331(22):1963-1965, doi: 10.1001/jama.2024.7395
[15] Chen HJ et al. Transfer of IgG from Long COVID patients induces symptomology in mice. BioRxiv 2024, doi: 10.1101/2024.05.30.596590
[16] Fouraté S. Symptome deutlich verbessert oder komplett verschwunden. Interview Studieninitiator Bernhard Schieffer, 18. Juni 2024, www.hessenschau.de/gesellschaft/neue-post-covid-studie-in-marburg-zeigt-erstaunliche-erfolge-v2,cholesterin-long-covid-100.html
[17] Grote K et al. Targeting the High-Density Lipoprotein Proteome for the Treatment of Post-Acute Sequelae of SARS-CoV-2. Int J Mol Sci 2024 20;25(8):4522, doi: 10.3390/ijms25084522
0 Kommentare
Das Kommentieren ist aktuell nicht möglich.